P Raina, P Santaguida, A Ismaila, C … - Annals of Internal Medicine, 2008 - Am Coll Physicians Purpose: To review the evidence for the effectiveness of cholinesterase
inhibitors (donepezil, galantamine, rivastigmine, and tacrine) and the
neuropeptide-modifying agent memantine in achieving clinically relevant ... Cited by 70 - Related articles - BL Direct - All 10 versions
A Qaseem, V Snow, JT Cross, MA Forciea, R … - Annals of Internal Medicine, 2008 - Am Coll Physicians From the American College of Physicians and University of Pennsylvania,
Philadelphia, Pennsylvania; Medstudy, Colorado Springs, Colorado; University of
Arkansas, Little Rock, Arkansas; Veterans Affairs Greater Los Angeles ... Cited by 34 - Related articles - BL Direct - All 31 versions
[CITATION] Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence …
B Winblad, G Grossberg, L Frolich, M Farlow, … - Neurology, 2007 - AAN Enterprises The rivastigmine patch is the first transdermal treatment for Alzheimer disease
(AD). By providing continuous delivery of drug into the bloodstream over 24
hours, transdermal delivery may offer benefits superior to those of oral ... Cited by 34 - Related articles - All 5 versions
N Herrmann, SS Gill, CM Bell, GM Anderson, … - Journal of the American Geriatrics Society, 2007 - ingentaconnect.com Elderly patients with dementia are treated for lengthy periods of time with
ChEIs in the community and in long-term care facilities. Further research is
required to determine whether these utilization patterns are appropriate. ... Cited by 11 - Related articles - BL Direct - All 2 versions
ML Onor, M Trevisiol, E Aguglia - Clinical Interventions in Aging, 2007 - pubmedcentral.nih.gov Alzheimer's disease is the most common form of dementia in industrialized
countries. In the European Union, about 54% of dementia cases are believed to be
due to Alzheimer's disease. The condition is an age-related ... Cited by 8 - Related articles - BL Direct - All 6 versions
FJ Molnar… - Open Medicine, 2009 - openmedicine.ca Background: Intention-to-treat analysis is used in the analysis of randomized
controlled trials to preserve trial power in the presence of missing subject
data as well as to control for both known and unknown confounding factors. ... Cited by 1 - Related articles - Cached - All 2 versions
ER Peskind, SG Potkin, N Pomara, BR Ott, SM … - American Journal of Geriatric Psych, 2006 - journals.lww.com Method: This was a randomized, double-blind, placebo-controlled clinical trial
conducted at 42 US sites. Participants were 403 outpatients with mild to
moderate AD and Mini-Mental State Examination scores of 10-22 randomized to ... Cited by 87 - Related articles - BL Direct - All 16 versions
M Mazza, A Capuano, P Bria, S Mazza - European Journal of Neurology, 2006 - dmmsclick.wiley.com The Ginkgo biloba special extract EGb 761 seems to produce neuroprotective
effects in neurodegenerative diseases of multifactorial origin. There is still
debate about the efficacy of Ginkgo biloba special extract EGb 761 compared ... Cited by 50 - Related articles - BL Direct - All 6 versions
